Jobs with Startups
JobsStartupsInvestorsMCP
Startups

Probably Genetic

Probably Genetic logo

Probably Genetic

Patient Intelligence Platform for Genetic Disease

probablygenetic.com
HQ: San Francisco, CA, USA
11-50
Healthcare

Company research

Public company, workplace, funding, and market signals

Updated Aug 16, 2026

Overview

Probably Genetic is a biotechnology company focused on helping undiagnosed rare-disease patients find answers through at-home genetic testing, symptom screening, genetic counseling, and a patient-data platform used to support rare-disease research and biopharma partnerships.

Primary product

An AI-driven rare-disease identification and sponsored genetic testing platform, including an online symptom checker, at-home DNA testing, physician review, and genetic counseling.

Founded

2019

Headquarters

San Francisco, California, United States

Team size

1-10 employees

Industry

Biotechnology Research

Sub-industry

Genetic testing / rare-disease diagnostics / precision medicine

Offices

655 Commercial St, San Francisco, CA 94111, United States
665 Third St, Unit 150, San Francisco, CA, United States
665 Third St, San Francisco, CA, United States

Business model

B2C direct-to-consumer testing
B2B sponsored testing programs with drug developers
research data partnerships

Funding

Stage

Series A

Total raised

$11.2M

Latest round

Venture Round / Series A · Nov 2023

Latest amount

$10.7M

Series A

Mar 2024

$10.7M

Venture Round

Nov 2023

$10.7M

Angel Round

Jan 2022

Seed Round

May 2020

Pre Seed Round

Mar 2019 · Y Combinator

$150K

People & investors

Leadership

Lukas Lange

Founder & CEO

Joshua Leven

VP of Engineering

Yasmeen Almog

VP Product

Michael J. Kyle

VP, People & Operations

Jennifer Clara Herrmann

Head of Research & Development

Jana Heyer

Lead Product Designer

Investors

Asymmetric Capital Partners
Khosla Ventures
Oxford Angel Fund
TenOneTen Ventures
Threshold Ventures
Unnamed angel investors
Y Combinator

Work & culture

Public posts and hiring language emphasize a mission-driven, patient-first culture, cross-functional collaboration, technical ownership, and fast-paced startup building for rare-disease care.

Compensation

Public hiring snippets indicate competitive salaries, comprehensive benefits, and early-stage equity; one external job listing surfaced a $200k-$250k salary range for Head of Engineering, but that should be treated as a third-party posting, not an official company-wide signal.

Benefits

competitive salaries
comprehensive benefits
meaningful early-stage equity

Product & market

Pricing

Patient testing is described as free to the patient, funded by drug developers; the company also appears to monetize via sponsored testing programs and research/data partnerships.

Differentiators

  • —AI-driven symptom screening to identify likely rare-disease patients
  • —Free or low/no-cost patient testing funded by sponsors
  • —At-home sample collection with physician review and counseling
  • —Rare-disease focus rather than broad consumer genomics
  • —Combines patient identification, diagnostics, and research/biopharma access in one workflow

Technology

terraform
iterable
numpy
sql
gmail
typescript
react
openai
html
databricks
hubspot
python
zendesk
twilio
postgresql
mlops
django
google workspace
ramp
linkedin engineering suite? (via job/stack listing) not confirmed as internal infrastructure

Customers

Undiagnosed rare-disease patients
Families seeking genetic testing and counseling
Drug developers / biopharma partners
Research institutions

Competitors

PreventionGenetics
color
Invitae
GeneDx
Nucleus (consumer genomics / adjacent)
other rare-disease diagnostics and genetic testing providers

Scale & contact

Estimated revenue

Likely pre-revenue to low single-digit millions USD annually; public evidence is insufficient for a precise estimate.

Estimated monthly visits

69.6K

Traffic estimate as of Jun 2026

Latest news

Probably Genetic company posts and hiring updates

LinkedIn · Jul 2026

Recent company posts discuss hiring a VP of Engineering, product hiring, and continued scale-up around rare-disease diagnostics.

Probably Genetic Secures $10.7M Series

Signalbase · Mar 2026

Funding-related coverage summarizing the round and the company’s rare-disease mission.

Startup wants to combine DNA, machine learning for earlier autism diagnosis

Genetic Literacy Project · Jun 2019

Explains the company’s initial testing concept and notes the planned pricing would be below $1,000.

Probably Genetic helps families identify genetic conditions early with AI and DNA tests

TechCrunch · Jun 2019

Early coverage describing the company’s original mission and product: machine learning plus direct-to-consumer DNA tests to help families obtain earlier diagnoses.

Probably Genetic — Company Profile & Funding

Indexed.vc

Aggregated profile indicating total funding of about $10.7M and a Series A in Mar 2024.

AMA / funding model explanationBlogCareers / jobsLinkedIn company page
SourcesCompany websiteLinkedIn company pageProbably Genetic blog: Genetic TrailblazersProbably Genetic AMA on funding modelTechCrunch coverage

Jobs and careers at Probably Genetic

6 jobs at Probably Genetic

Head of Community Marketing

Remote
Marketing
San Francisco; San Francisco, California, USA
1w ago
Remote
Full-time
Apply

Forward Deployed Product Manager

On-site
Product
San Francisco; San Francisco, California, USA
2w ago
On-site
Full-time
Apply

Community Marketing Manager

Remote
Marketing
San Francisco
2mo ago
Remote
Full-time
Apply

Senior Data Scientist

Remote
Product
San Francisco
3mo ago
Remote
Full-time
Apply

Director of Strategic Partnerships

Remote
Business
San Francisco
3mo ago
Remote
Full-time
Apply

Senior Software Engineer

Remote
Engineering
San Francisco
10mo ago
Remote
Full-time
Apply

Explore startup hiring

Startup Hiring PulseBrowse all startup jobsJobs at Y Combinator startupsJobs at early-stage startupsJobs at venture-backed startupsHealthcare startup jobs

Jobs with Startups © 2026

Browse jobsMCP guideAboutPowered by Supabase